In 1997, genetic analysis of patients with PCa from Iceland with positive BRCA2 family background showed that approximately 66% of the cases had BRCA2 mutations.19 This was the first time that BRCA2 was associated with PCa, thereby providing an important link between breast or ovarian cancer and PCa. This evidence concerns the gene BRCA2 and ovarian carcinoma.